Literature DB >> 17353399

High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women.

Debra A Schaumberg1, William G Christen, Julie E Buring, Robert J Glynn, Nader Rifai, Paul M Ridker.   

Abstract

OBJECTIVE: To investigate whether high-sensitivity C-reactive protein (hsCRP) and other biomarkers of inflammation predict age-related macular degeneration (AMD).
METHODS: We measured hsCRP, soluble intercellular adhesion molecule-1 (sICAM-1), and fibrinogen levels in baseline plasma samples from 27 687 participants with a mean age of 54.6 years and initially free of AMD in the Women's Health Study. We prospectively ascertained 150 cases of AMD with vision loss of 20/30 or worse in the affected eye by self-report confirmed with review of medical records during 275 852 person-years of follow-up (mean = 10 years) and used proportional hazards models to examine the relationship between these biomarkers and AMD.
RESULTS: After adjustment for multiple risk factors, the hazard ratio (HR) (95% confidence interval [CI]) of AMD, contrasting the highest vs lowest quintile of hsCRP, was 3.09 (1.39-6.88) (P trend = .02). In similar models, the HR (95% CI) for sICAM-1 was 1.87 (0.97-3.58) (P trend = .07). The relationship between fibrinogen and AMD was J-shaped, with an HR (95% CI) of 2.01 (1.07-3.75) for women in the highest fifth vs second fifth.
CONCLUSION: Elevated circulating levels of hsCRP, sICAM-1, and fibrinogen precede the development of visually significant AMD in women, providing further support for the hypothesis that inflammation may play a role in AMD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353399      PMCID: PMC3037008          DOI: 10.1001/archopht.125.3.300

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  53 in total

1.  A potential role for immune complex pathogenesis in drusen formation.

Authors:  L V Johnson; S Ozaki; M K Staples; P A Erickson; D H Anderson
Journal:  Exp Eye Res       Date:  2000-04       Impact factor: 3.467

Review 2.  Inflamm-aging. An evolutionary perspective on immunosenescence.

Authors:  C Franceschi; M Bonafè; S Valensin; F Olivieri; M De Luca; E Ottaviani; G De Benedictis
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

3.  Risk factors in age-related maculopathy complicated by choroidal neovascularization.

Authors:  M S Blumenkranz; S R Russell; M G Robey; R Kott-Blumenkranz; N Penneys
Journal:  Ophthalmology       Date:  1986-05       Impact factor: 12.079

Review 4.  Circulating adhesion molecules in disease.

Authors:  A J Gearing; W Newman
Journal:  Immunol Today       Date:  1993-10

5.  Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.

Authors:  H K Meier-Ewert; P M Ridker; N Rifai; N Price; D F Dinges; J M Mullington
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

6.  Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2.

Authors:  W L Roberts; L Moulton; T C Law; G Farrow; M Cooper-Anderson; J Savory; N Rifai
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

Review 7.  Leucocyte-endothelial interactions and regulation of leucocyte migration.

Authors:  D H Adams; S Shaw
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

8.  Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study.

Authors:  T L van der Schaft; C M Mooy; W C de Bruijn; P T de Jong
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

Review 9.  Fibrinogen and cardiovascular disorders.

Authors:  G Y Lip
Journal:  QJM       Date:  1995-03

10.  Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus.

Authors:  B O Roep; E Heidenthal; R R de Vries; H Kolb; S Martin
Journal:  Lancet       Date:  1994-06-25       Impact factor: 79.321

View more
  33 in total

1.  Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells.

Authors:  Qingning Bian; Shasha Gao; Jilin Zhou; Jian Qin; Allen Taylor; Elizabeth J Johnson; Guangwen Tang; Janet R Sparrow; Dennis Gierhart; Fu Shang
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

2.  [Age-related macular degeneration and risk of stroke].

Authors:  V Biousse; M-G Bousser; A Gaudric
Journal:  J Fr Ophtalmol       Date:  2008-01       Impact factor: 0.818

3.  Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degeneration.

Authors:  Nurgül Örnek; Kemal Örnek; Süleyman Aydin; Musa Yilmaz; Yaşar Ölmez
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

4.  The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.

Authors:  L-Y Ngai; N Stocks; J M Sparrow; R Patel; A Rumley; G Lowe; G Davey Smith; Y Ben-Shlomo
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

5.  C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration.

Authors:  Johanna M Seddon; Gary Gensler; Bernard Rosner
Journal:  Ophthalmology       Date:  2010-03-26       Impact factor: 12.079

6.  Periodontal Diseases and Age-Related Macular Degeneration: Is There a Link? A Review.

Authors:  Zocko Ange Désiré Pockpa; Xavier Struillou; Dramane Kone; Gnaba Samson Mobio; Assem Soueidan; Zahi Badran
Journal:  Perm J       Date:  2019-10-25

7.  The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.

Authors:  Shaza N Al-Holou; William R Tucker; Elvira Agrón; Traci E Clemons; Catherine Cukras; Frederick L Ferris; Emily Y Chew
Journal:  Ophthalmology       Date:  2015-10-04       Impact factor: 12.079

8.  Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration.

Authors:  Robyn Guymer; Tania Cipriani; Kay D Rittenhouse; Lyndell Lim; Liubov D Robman; Wenlin Li; Wenlian Wang; Shibing Deng; Poulabi Banerjee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-07       Impact factor: 3.117

9.  Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies.

Authors:  Debra A Schaumberg; Lynda Rose; Margaret M DeAngelis; Richard D Semba; Gregory S Hageman; Daniel I Chasman
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

10.  Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort.

Authors:  Jie Jin Wang; Elena Rochtchina; Wayne Smith; Ronald Klein; Barbara E K Klein; Tripti Joshi; Theru A Sivakumaran; Sudha Iyengar; Paul Mitchell
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.